• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Low diastolic blood pressure associated with higher mortality in chronic kidney disease

bys25qthea
August 22, 2013
in Cardiology, Chronic Disease, Nephrology
Reading Time: 3 mins read
Low diastolic blood pressure associated with higher mortality in chronic kidney disease
Share on FacebookShare on Twitter

Image: PD

1.  Among US veterans with non-dialysis dependent chronic kidney disease, diastolic blood pressure lower than 70 mm Hg was associated with higher mortality even when systolic blood pressure was within the ideal range. 

Evidence Rating Level: 2 (Good)            

Study Rundown: The association between high blood pressure (BP) and increased risk for cardiovascular disease and death has been well established in the general population. Current hypertension treatment guidelines in both chronic kidney disease (CKD) patients and patients with normal renal function emphasize tight control of systolic blood pressure (SBP) without much regard to diastolic blood pressure (DBP). However, recent studies have shown that low DBP, independent of SBP, may be a risk factor for higher mortality. This research is especially relevant in CKD patients, whose unique vascular physiology often results in high pulse pressures and low DBP. This study showed that non-dialysis dependent CKD patients with BP in the range of 130-159/70-89 mmHg had the lowest mortality rates.  That is, despite mild systolic hypertension, patients who maintained their DBP above 70 mm Hg had the best outcomes.  “Normal” blood pressure (<130/80 mmHg) was actually associated with the highest risk of mortality because of the inclusion of patients with DBP<70 mmHg.  A key major limitation is observational nature of this nature, and thus, causal relationships cannot be established from these results.  Furthermore, the study is limited by its population, which was comprised of primarily white males. Nonetheless, results of this study suggest that achieving ideal SBP at the expense of low DBP may increase risk of mortality in patients with non-dialysis dependent CKD.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

2 Minute Medicine Rewind September 7, 2026

A health coaching intervention may improve blood pressure control in postpartum women

In-Depth [retrospective cohort study]: This study analyzed data from 651,749 US veterans with non-dialysis dependent CKD, available BP measurements, and sufficient follow-up for survival analysis between 2005 and 2012. They divided the cohort into 96 categories based on all possible combinations of SBP and DBP from lowest (<80/<40 mm Hg) to highest (>210/>120 mm Hg) in 10-mm Hg increments. The authors used time-dependent Cox models to determine the association between SBP-DBP combination and all-cause mortality, adjusting for age, sex, race, diabetes mellitus, cardiovascular and cerebrovascular disease, chronic heart failure, Charlson Comorbidity Index scores, medication use, eGFR’s, and blood cholesterol levels.

238,640 patients in the study cohort died during a median follow-up of 5.8 years. When analyzed separately, both SBP and DBP showed a U-shaped association with mortality, with higher mortality associated with lower and higher BP values. The best outcomes were associated with SBP of 140-160 mm Hg or DBP of 80-90 mm Hg. When SBP and DBP were analyzed as combinations, BP’s of 130-159/70-89 were associated with the lowest mortality rates in adjusted analyses. Interestingly, combinations of lower SBP and DBP were associated with lower mortality only when DBP was greater than approximately 70 mm Hg, regardless of how low the patient’s SBP was kept.  For example, when comparing a combination BP of 130-139/70-79 to 110-119/60-69, the mortality HR increased from 1.01 to 1.48.

By Sarah Chuzi and Aimee Li, MD

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: blood pressurechronic kidney disease
Previous Post

Haloperidol for ICU delirium: No effect on duration or incidence versus placebo

Next Post

Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

RelatedReports

Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Next Post
Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

Diabetic patients report improved vision after ranibizumab treatment

Diabetic patients report improved vision after ranibizumab treatment

Remote ischemic preconditioning reduced myocardial injury in CABG patients

Remote ischemic preconditioning reduced myocardial injury in CABG patients

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.